Moolec Science (MLEC) Treasury Shares (2024)

Moolec Science's (MLEC) quarterly Treasury Shares came in at -$1232.0 in Q4 2024, little changed quarter-over-quarter from -$1232.0 in Q3 2024.

Moolec Science (MLEC) Treasury Shares (2024) Analysis & Trends

Moolec Science has disclosed Treasury Shares across 1 years of filings, most recently posting -$1232.0 for Q4 2024.

Treasury Shares for Q4 2024 came in at -$1232.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was -$1232.0 (changed N/A YoY), and the FY2024 annual result was -$1232.0, changed N/A from the prior year.
Treasury Shares came in at -$1232.0 for Q4 2024 at Moolec Science, roughly flat from -$1232.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of -$1032.0 in Q1 2024 to a low of -$1232.0 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-	-
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-	-
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-	-
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-	-
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-	1.48 Mn
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn	700,000.00
9	Abivax	94.26 Bn	94.26 Bn	-	-
10	Moolec Science	6.98 Bn	6.98 Bn	-	-

Download Data